FDA Approved: SUPRANE — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

FDA approved a supplemental application for SUPRANE (desflurane) by Baxter Healthcare Corporation, updating labeling details for the anesthetic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• General Anesthesia

Drugs mentioned

• SUPRANE (DESFLURANE)

Snippet

SUPPL AP for SUPRANE (DESFLURANE)